News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nuon Therapeutics Inc. Announces Gout Program Study Results to Be Presented at the American College of Rheumatology


9/29/2010 10:13:29 AM

SAN MATEO, Calif.--(BUSINESS WIRE)--Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced today that results from a clinical evaluation of its lead program in gout, NU1618, and pre-clinical data describing the mechanism of action for the tranilast component of NU1618, have been accepted for presentation at the 2010 American College of Rheumatology/Association of Rheumatology Health Professionals (ACP/ARHP) Annual Scientific Meeting, to be held in Atlanta, GA, November 6-11.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES